Location: Luxembourg
CIK: 0001834239 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 13, 2026
Total Value: $863M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| OCS | OCULIS HOLDING AG | 6,950,294 (+17.8%) | $96.4M (-38.6%) | 11.2% | — | — | ORDINARY SHARES | H5870P102 |
| EVMN | EVOMMUNE INC | 5,288,313 (+7.3%) | $70.28M (-38.0%) | 8.1% | — | — | COM SHS | 30054Y107 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| WAY | WAYSTAR HLDG CORP | 24,879,437 | $511M | 59.2% | — | — | COM | 946784105 |
| PHVS | PHARVARIS N V | 3,424,609 | $118M | 13.7% | — | — | COM | N69605108 |
| AGMB | AGOMAB THERAPEUTICS NV | 5,141,992 | $66.74M | 7.7% | — | — | SPONSORED ADS | 00860C102 |